StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SOONER OR LATER

<< Previous

Bullboard Posts

Next >>

Post by capebretongirlon Mar 03, 2021 9:57am

203 Views

Post# 32703806

SOONER OR LATER

Investors are going to figure out that today's EXRO will be tomorrow's SZLS in terms of jumping up. Can't believe with Aristotle news imminent that the volume here is so low - show me one other stock where Q4 revenue is practically guaranteed to be huge and a revolutionary rollout is about to happen. I guess investors are willing to pay the much higher sp after the rollout as at that point the "seeing is believing" principle will be in place. GLTA!

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario